These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9421280)

  • 41. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexmedetomidine selectively suppresses dominant behaviour in aggressive and sociable mice.
    Votava M; Hess L; Slíva J; Krsiak M; Agová V
    Eur J Pharmacol; 2005 Oct; 523(1-3):79-85. PubMed ID: 16226250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors.
    Poree LR; Guo TZ; Kingery WS; Maze M
    Anesth Analg; 1998 Oct; 87(4):941-8. PubMed ID: 9768799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
    Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli.
    Saeki S; Yaksh TL
    J Pharmacol Exp Ther; 1992 Feb; 260(2):795-802. PubMed ID: 1346645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexmedetomidine prolongs spinal anaesthesia induced by levobupivacaine 0.5% in guinea-pigs.
    Calasans-Maia JA; Zapata-Sudo G; Sudo RT
    J Pharm Pharmacol; 2005 Nov; 57(11):1415-20. PubMed ID: 16259773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
    Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
    Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antinociceptive effects and pharmacological properties of JM-1232(-): a novel isoindoline derivative.
    Chiba S; Nishiyama T; Yamada Y
    Anesth Analg; 2009 Mar; 108(3):1008-14. PubMed ID: 19224817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.
    Franowicz JS; Kessler LE; Borja CM; Kobilka BK; Limbird LE; Arnsten AF
    J Neurosci; 2002 Oct; 22(19):8771-7. PubMed ID: 12351753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
    Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS
    Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn.
    Tamagaki S; Suzuki T; Hagihira S; Hayashi Y; Mashimo T
    J Pharm Pharmacol; 2010 Dec; 62(12):1760-7. PubMed ID: 21054403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice.
    Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
    J Neurosci; 1998 Apr; 18(8):3035-42. PubMed ID: 9526020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
    Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
    Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord.
    Fairbanks CA; Kitto KF; Nguyen HO; Stone LS; Wilcox GL
    Anesthesiology; 2009 Mar; 110(3):638-47. PubMed ID: 19212267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype.
    Ma D; Hossain M; Rajakumaraswamy N; Arshad M; Sanders RD; Franks NP; Maze M
    Eur J Pharmacol; 2004 Oct; 502(1-2):87-97. PubMed ID: 15464093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of radolmidine, a novel alpha2 -adrenergic agonist compared with dexmedetomidine in different pain models in the rat.
    Xu M; Kontinen VK; Kalso E
    Anesthesiology; 2000 Aug; 93(2):473-81. PubMed ID: 10910498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
    Schwinn DA; Correa-Sales C; Page SO; Maze M
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Function of brain α
    Luhrs L; Manlapaz C; Kedzie K; Rao S; Cabrera-Ghayouri S; Donello J; Gil D
    Neuroscience; 2016 Dec; 339():608-621. PubMed ID: 27751959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
    Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
    J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.